Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,290 | -116,045 | -87,222 | -64,564 | -33,407 |
| Depreciation Amortization | 1,521 | 1,198 | 1,921 | 1,562 | 916 |
| Accounts receivable | -1,072 | 1,968 | 438 | 858 | 441 |
| Accounts payable and accrued liabilities | -168 | -414 | 1,124 | 261 | 5,174 |
| Other Working Capital | 113 | 7,130 | -2,034 | -4,729 | -1,382 |
| Other Operating Activity | 5,095 | 27,399 | 17,409 | 13,023 | 3,270 |
| Operating Cash Flow | $-16,801 | $-78,764 | $-68,364 | $-53,589 | $-24,988 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,745 | -17,948 | -8,997 | -2,455 | -787 |
| Purchase Of Investment | N/A | -307,282 | -307,283 | -212,134 | -146,845 |
| Sale Of Investment | 77,648 | 383,465 | 355,442 | 260,096 | 134,515 |
| Investing Cash Flow | $68,903 | $58,235 | $39,162 | $45,507 | $-13,117 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 94 | 147 | 79 | 51 | N/A |
| Other Financing Activity | -5,080 | -27,773 | -20,490 | -13,815 | -7,350 |
| Financing Cash Flow | $-4,986 | $-27,626 | $-20,411 | $-13,764 | $-7,350 |
| Beginning Cash Position | 41,201 | 89,356 | 89,356 | 89,356 | 89,356 |
| End Cash Position | 88,317 | 41,201 | 39,743 | 67,510 | 43,901 |
| Net Cash Flow | $47,116 | $-48,155 | $-49,613 | $-21,846 | $-45,455 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,801 | -78,764 | -68,364 | -53,589 | -24,988 |
| Capital Expenditure | -8,745 | -17,948 | -8,997 | -2,455 | -787 |
| Free Cash Flow | -25,546 | -96,712 | -77,361 | -56,044 | -25,775 |